about
Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation.Effect of cyclodextrins and pH on the permeation of tetracaine: supramolecular assemblies and release behavior.Supramolecular gels of poly-α-cyclodextrin and PEO-based copolymers for controlled drug release.Transport properties in aqueous ethambutol dihydrochloride.Multicomponent complex formation between vinpocetine, cyclodextrins, tartaric acid and water-soluble polymers monitored by NMR and solubility studies.Compaction, compression and drug release properties of diclofenac sodium and ibuprofen pellets comprising xanthan gum as a sustained release agent.Development and validation of a rapid reversed-phase HPLC method for the determination of insulin from nanoparticulate systems.Nanoparticulate delivery system for insulin: design, characterization and in vitro/in vivo bioactivity.New delivery systems to improve the bioavailability of resveratrol.Microwave synthesis and in vitro stability of diclofenac-β-cyclodextrin conjugate for colon delivery.Ultrasonication of insulin-loaded microgel particles produced by internal gelation: impact on particle's size and insulin bioactivity.Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems.Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.The systems containing clays and clay minerals from modified drug release: a review.Advance in methods studying the pharmacokinetics of polyphenols.Recent advances in characterization of nonviral vectors for delivery of nucleic acids: impact on their biological performance.Intestinal uptake of insulin nanoparticles: facts or myths?Polymeric micelles for oral drug administration enabling locoregional and systemic treatments.Why most oral insulin formulations do not reach clinical trials.Gums' based delivery systems: Review on cashew gum and its derivatives.Smart micelleplexes as a new therapeutic approach for RNA delivery.Recent Advances in Nucleic Acid-Based Delivery: From Bench to Clinical Trials in Genetic Diseases.Preparation methods and applications behind alginate-based particles.Poloxamine-cyclodextrin-simvastatin supramolecular systems promote osteoblast differentiation of mesenchymal stem cells.Sex differences in excipient effects: Enhancement in ranitidine bioavailability in the presence of polyethylene glycol in male, but not female, rats.The role of L-arginine in inclusion complexes of omeprazole with cyclodextrinsA comprehensive development strategy in buccal drug deliveryPreparation of calcium alginate nanoparticles using water-in-oil (W/O) nanoemulsions.Preparation and solid-state characterization of inclusion complexes formed between miconazole and methyl-beta-cyclodextrin.Single and mixed poloxamine micelles as nanocarriers for solubilization and sustained release of ethoxzolamide for topical glaucoma therapy.Effects of galactose on direct and indirect pathway estimates of hepatic glycogen synthesis.Combining strategies to optimize a gel formulation containing miconazole: the influence of modified cyclodextrin on textural properties and drug release.Influence of the coating formulation on enzymatic digestibility and drug release from 5-aminosalicylic acid pellets coated with mixtures of high-amylose starch and Surelease intended for colon-specific drug delivery.Encapsulation of DNA in macroscopic and nanosized calcium alginate gel particles.Design for optimization of nanoparticles integrating biomaterials for orally dosed insulin.Influence of the preparation method on the physicochemical properties of tolbutamide/cyclodextrin binary systems.Molecular modelling and 1H-NMR: ultimate tools for the investigation of tolbutamide: beta-cyclodextrin and tolbutamide: hydroxypropyl-beta-cyclodextrin complexes.Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds.Physical properties of chitosan pellets produced by extrusion-spheronisation: influence of formulation variables.
P50
Q30379795-C40C3985-F3DF-45E9-BF59-4AE9D00D21E0Q30783550-06F5BBDC-18EF-4122-88BB-48042621A332Q30809768-7A53F839-1A86-4D51-B286-CF081751459EQ30882119-48F19082-6403-4232-B3A9-64AEED297C4DQ30979533-EAA8F058-C05A-4485-B8F8-0AAA4518D355Q33215207-1FD5C1EA-7DE4-4578-84DE-A859D94AB21AQ33230716-41FA6767-CC85-4D5E-B307-F8C47B698A40Q33272232-66F8E407-CB5F-424E-AF41-2DCEAC62D78FQ34192059-4D53D9A6-4C5A-46E3-9187-BAAD2012A794Q34624052-5A2457E9-45A5-4F52-AD46-594D191A3771Q34993230-9D22EBB5-86C8-4594-9EA9-DE901C2EEFCEQ36733054-7F70A522-570B-4A39-B432-D831CAC00E41Q36733067-572ACF7C-F04C-47A1-A948-3FD45583C9CEQ36917923-DA2CE53B-C140-446D-8631-D2560000593AQ38068622-1D7C7A87-641D-4AF6-A34C-71074B0CD7A4Q38170447-69AE0ACD-AC96-496E-862A-7F4F5151EA3AQ38241667-334780D5-333C-4EEC-9AAD-8614D2E5F813Q38249002-D876A053-CFCF-49A8-AC92-AC54BF17D6D6Q38250152-9B696BBC-25AD-4D92-8CEF-3592436382D9Q38566437-3484AB3B-BBCD-47D4-B807-76530A0E94DCQ38834344-749B6575-3EAF-47D1-B4C4-CBBA059F6F5CQ38840111-0D01C2CF-EF66-418C-9195-DBF9FCBDA903Q38865879-08AC437A-95E9-4838-BCFF-9A525C03DAB8Q38918979-07BA6E32-9ED5-47B7-B40F-AF019C186649Q39162050-11260DAE-A2CB-4DBE-A1B5-F840BD9CB2E0Q39845710-9D2732D8-EA13-4FA5-AA1C-F47E8F0B2FBCQ39923600-77170771-CE2A-43BC-916F-75C424FE884FQ41500341-CA700CC9-46B5-4922-A427-29DF72496682Q41614163-46E92393-D9C2-4DA2-9B84-D7DFF32E1E2BQ41849621-AE6D1DE5-9874-4839-BDDB-DBCCAB3A3024Q42251010-BCB3A44C-B77B-46E9-BFE5-9595A36B8E04Q42924879-B73BB1FC-8261-43B8-A9A7-E0D86BABF420Q43202100-EE3053A7-7E96-4CD8-A504-D378C0101D11Q43292547-2A68D749-8BF3-489C-AF5A-CBB590CD19DAQ43473915-9C4FAA5F-A036-4788-82B2-86C4ACBA67D9Q43682110-399942E3-F76C-4718-A141-96BA2F0AC0A4Q43731646-2A57FA92-8603-4445-A929-9881D6923897Q43769552-E39E0E0C-B2C5-47C2-97B6-74CE434547FBQ43861621-A5D0232D-5B05-4972-A4D2-D9D4A0DF1626Q44149129-2FE22B39-77B9-4611-BF82-78F7E4C7FFCE
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Francisco Veiga
@ast
Francisco Veiga
@en
Francisco Veiga
@es
Francisco Veiga
@nl
Francisco Veiga
@sl
type
label
Francisco Veiga
@ast
Francisco Veiga
@en
Francisco Veiga
@es
Francisco Veiga
@nl
Francisco Veiga
@sl
altLabel
Jose Francisco Veiga
@en
prefLabel
Francisco Veiga
@ast
Francisco Veiga
@en
Francisco Veiga
@es
Francisco Veiga
@nl
Francisco Veiga
@sl
P1053
L-4884-2014
P106
P1153
35567448700
P21
P31
P3829
P496
0000-0002-1041-0068